Mechanistically, β5i was found to promote the degradation of ATRAP (AT 1 Receptor−Associated Protein), thereby activating AT1R (Angiotensin II Type 1 Receptor)-mediated signals, which in turn activatess receptor signaling, driving the retinopathy [77]. This evidence concerns the gene AGTR1 and retinal disorder.